In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kathy Fernando, Senior Vice President and Global Head of Pfizer Ignite and Pfizer CentreOne.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kathy, covering:

• How the forgotten step-child that is mRNA rose to the top of the technology vaccine tree

Kathy is a Senior Vice President and Global Head of the Pfizer Ignite Organization, and the Global Head of Pfizer CentreOne, within the Business Innovation Office at Pfizer. Her prior roles at Pfizer include Head of Worldwide Research, Development & Medical Operations and Head of mRNA scientific strategy. She also led efforts to develop an ambitious and holistic scientific strategy for mRNA across therapeutic areas as well as a well-orchestrated plan for execution.

Prior to joining Pfizer, she worked at Deloitte, helping address diverse business needs for pharmaceutical and biotech companies in the US and EU. Kathy has a Ph.D. in Immunology from the University of Pennsylvania. Her Ph.D. thesis focused on mRNA vaccine and HIV vaccine development. She has a bachelor’s degree in biotechnology from the Indian Institute of Technology (I.I.T) in Kharagpur, India.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.